Department of Life Sciences and Biotechnology, University of Ferrara, Italy.
IRET Foundation, Ozzano Emilia, Bologna, Italy.
J Alzheimers Dis. 2018;61(1):389-399. doi: 10.3233/JAD-170699.
Based on the pivotal role of astrocytes in brain homeostasis and the strong metabolic cooperation existing between neurons and astrocytes, it has been suggested that astrocytic dysfunctions might cause and/or contribute to neuroinflammation and neurodegenerative processes. Therapeutic approaches aimed at both neuroprotection and neuroinflammation reduction may prove particularly effective in slowing the progression of these diseases. The endogenous lipid mediator palmitoylethanolamide (PEA) displayed neuroprotective and anti(neuro)inflammatory properties, and demonstrated interesting potential as a novel treatment for Alzheimer's disease.
We firstly evaluated whether astrocytes could participate in regulating the Aβ42-induced neuronal damage, by using primary mouse astrocytes cell cultures and mixed astrocytes-neurons cultures. Furthermore, the possible protective effects of PEA against Aβ42-induced neuronal toxicity have also been investigated by evaluating neuronal viability, apoptosis, and morphometric parameters.
The presence of astrocytes pre-exposed to Aβ42 (0.5μM; 24 h) induced a reduction of neuronal viability in primary mouse astrocytes-neurons co-cultures. Furthermore, under these experimental conditions, an increase in the number of neuronal apoptotic nuclei and a decrease in the number of MAP-2 positive neurons were observed. Finally, astrocytic Aβ42 pre-exposure induced an increase in the number of neurite aggregations/100μm as compared to control (i.e., untreated) astrocytes-neurons co-cultures. These effects were not observed in neurons cultured in the presence of astrocytes pre-exposed to PEA (0.1μM), applied 1 h before and maintained during Aβ42 treatment.
Astrocytes contribute to Aβ42-induced neurotoxicity and PEA, by blunting Aβ42-induced astrocyte activation, improved neuronal survival in mouse astrocyte-neuron co-cultures.
基于星形胶质细胞在大脑稳态中的关键作用,以及神经元和星形胶质细胞之间存在的强烈代谢合作,人们认为星形胶质细胞功能障碍可能导致和/或促成神经炎症和神经退行性过程。旨在同时进行神经保护和减少神经炎症的治疗方法可能在减缓这些疾病的进展方面特别有效。内源性脂质介质棕榈酰乙醇酰胺 (PEA) 具有神经保护和抗炎(神经)特性,并显示出作为阿尔茨海默病新治疗方法的有趣潜力。
我们首先通过使用原代小鼠星形胶质细胞培养物和混合星形胶质细胞-神经元培养物来评估星形胶质细胞是否能够参与调节 Aβ42 诱导的神经元损伤。此外,还通过评估神经元活力、细胞凋亡和形态计量学参数来研究 PEA 对 Aβ42 诱导的神经元毒性的可能保护作用。
预先暴露于 Aβ42(0.5μM;24 小时)的星形胶质细胞存在于原代小鼠星形胶质细胞-神经元共培养物中会导致神经元活力降低。此外,在这些实验条件下,观察到神经元凋亡核数量增加和 MAP-2 阳性神经元数量减少。最后,与对照(即未经处理)星形胶质细胞-神经元共培养物相比,星形胶质细胞 Aβ42 预先暴露诱导了更多的神经突聚集/100μm。在存在预先暴露于 PEA(0.1μM)的星形胶质细胞的神经元中未观察到这些作用,PEA 在 Aβ42 处理前 1 小时施加并在整个 Aβ42 处理期间保持。
星形胶质细胞通过阻断 Aβ42 诱导的星形胶质细胞激活,在小鼠星形胶质细胞-神经元共培养物中改善神经元存活,从而促进 Aβ42 诱导的神经毒性,PEA 可改善神经元存活。